Fibroblast, Inc. — Form D
Fibroblast, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-16. The offering totals $5.0M, of which $2.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-01-16
- Form: D
- Accession: 0000897069-18-000026
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.0M
- Remaining: $3.0M
- Investors: 3
- Date of first sale: 2018-01-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303268
Issuer
- Name: Fibroblast, Inc.
- CIK: 0001587278
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 640 N. LaSalle Drive, CHICAGO, IL, 60654
- Phone: (800) 396-6463
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Andrew Albert | Executive Officer | DEL MAR, CA |
| Andrew Albert | Director | DEL MAR, CA |
| Eric Alvarez | Executive Officer | Chicago, IL |
| CHRISTOPHER CAPPS | Director | NEW YORK, NY |
| Scott Vold | Director | Chicago, IL |
| Scott Vold | Executive Officer | Chicago, IL |
| Scott Vold | Promoter | Chicago, IL |
| Mark Luy | Executive Officer | Chicago, IL |
| Kirk Elder | Director | Chicago, IL |
| Elias Pearson | Director | Chicago, IL |
| Jordan Dolin | Director | Chicago, IL |
| Kevin Weinstein | Director | Chicago, IL |
Other filings by this issuer (2)
More